A Repository to Study Host-Microbiome Interactions in Health and Disease
Launched by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) · Dec 16, 2022
Trial Information
Current as of February 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on studying the microbiome, which refers to the tiny bacteria and microorganisms that live in and on our bodies. Researchers believe that the microbiome plays a crucial role in our health and in how our bodies respond to illnesses. To better understand these interactions, the study aims to collect samples from the microbiomes of different groups of people, including healthy individuals, pregnant women, and children with certain illnesses. These samples will be stored for future research to help us learn more about how the microbiome impacts our health.
If you or someone you know is interested in participating, you need to be at least 3 years old and willing to provide biological samples like stool, saliva, or blood, among others. Participants will fill out a questionnaire about their health and diet, and most sample collections can be done at home with simple instructions. This study is currently recruiting participants of all ages and genders. It’s a great opportunity to contribute to important research that could improve our understanding of health and disease.
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- • Aged \>0 years. Only participants \>3 years old will be seen at the NIH CC.
- • Willing to allow biological samples and data to be stored for future research.
- • Willing to provide at least one of the requested biospecimens.
- EXCLUSION CRITERIA:
- • An individual who has any condition that, in the judgment of the investigator, may put them at undue risk or make them unsuitable for participation in the study will be excluded.
- • For additional gastrointestinal and skin biopsies only, individuals on blood thinners unless they have already been stopped for the procedure.
- • For additional gastrointestinal biopsies only, individuals who have a history of gastrointestinal perforation with endoscopic biopsies will be excluded from the collection of additional gastrointestinal biopsies for the repository.
- • For additional gastrointestinal biopsies only, healthy children (\<18 years old).
- • For skin biopsies only, individuals who have a history of keloid formation.
- • For vaginal swabs and vaginal fluid only, individuals who have not started menses.
- • For breast milk only, non-lactating individuals.
Trial Officials
Suchitra K Hourigan, M.D.
Principal Investigator
National Institute of Allergy and Infectious Diseases (NIAID)
About National Institute Of Allergy And Infectious Diseases (Niaid)
The National Institute of Allergy and Infectious Diseases (NIAID) is a key component of the National Institutes of Health (NIH) dedicated to advancing the understanding, prevention, and treatment of infectious and immune-mediated diseases. Through rigorous clinical trials, NIAID aims to foster innovative research that enhances public health and addresses global health challenges, including emerging infectious diseases and allergies. The institute collaborates with various partners, including academic institutions, industry, and international organizations, to translate scientific discoveries into effective therapies and vaccines. NIAID's commitment to high-quality clinical research is integral to improving health outcomes and informing policy decisions in the realm of infectious diseases and immunology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials